Tom Valentino

News
Applications Being Accepted for SUD Treatment and Recovery Loan Repayment Program
06/11/2021
HRSA is now accepting applications for its $28 million Substance Use Disorder Treatment and Recovery Loan Repayment Program (STAR LRP) that will provide up to $250,000 in eligible education loan repayment funds for those working in the field...
HRSA is now accepting applications for its $28 million Substance Use Disorder Treatment and Recovery Loan Repayment Program (STAR LRP) that will provide up to $250,000 in eligible education loan repayment funds for those working in the field...
HRSA is now accepting...
06/11/2021
Addiction Professional
News
Psychedelics Briefs: Field Trip, Cybin Receive Conditional Stock Listing Approvals; Mydecine Applies for Patent
07/27/2021
Field Trip Health has received conditional approval to list shares on the NASDAQ Global Select Market, and Cybin has received similar approval from the NYSE American stock exchange. Mydecine, meanwhile, has filed for a new patent for...
Field Trip Health has received conditional approval to list shares on the NASDAQ Global Select Market, and Cybin has received similar approval from the NYSE American stock exchange. Mydecine, meanwhile, has filed for a new patent for...
Field Trip Health has received...
07/27/2021
Behavioral Healthcare Executive
News
Hazelden Betty Ford Nears 90% Staff Vaccination Rate After Mandate
08/27/2021
After Hazelden Betty Ford implemented a requirement for all staff members to receive a COVID-19 vaccination in May, CEO Joseph Lee, MD, says a combination of healthy dialogue and contingency management initiatives have led to 88.3% of the...
After Hazelden Betty Ford implemented a requirement for all staff members to receive a COVID-19 vaccination in May, CEO Joseph Lee, MD, says a combination of healthy dialogue and contingency management initiatives have led to 88.3% of the...
After Hazelden Betty Ford...
08/27/2021
Behavioral Healthcare Executive
News
DEA Issues Alert on Counterfeit Pills Containing Fentanyl
09/28/2021
DEA has issued a Public Safety Alert—its first in 6 years—in response to what it describes as an alarming increase in the lethality and availability of counterfeit prescription pills containing fentanyl and methamphetamine.
DEA has issued a Public Safety Alert—its first in 6 years—in response to what it describes as an alarming increase in the lethality and availability of counterfeit prescription pills containing fentanyl and methamphetamine.
DEA has issued a Public Safety...
09/28/2021
Addiction Professional
News
Business Briefs: Pear Digital Therapeutics, Integrated Psychiatric Consultants, Brookdale Premier Addiction Recovery
10/29/2021
Massachusetts becomes the first state to have a Medicaid program cover prescription digital therapeutics for SUD, Integrated Psychiatric Consultants has added 2 programs, and Brookdale Premier Addiction Recovery in Pennsylvania is adding an...
Massachusetts becomes the first state to have a Medicaid program cover prescription digital therapeutics for SUD, Integrated Psychiatric Consultants has added 2 programs, and Brookdale Premier Addiction Recovery in Pennsylvania is adding an...
Massachusetts becomes the first...
10/29/2021
Behavioral Healthcare Executive
News
Business Briefs: Pear Therapeutics, Banyan, Verinetics, Integrated Services for Behavioral Health, Mindpath Health
12/03/2021
Pear Therapeutics has received Breakthrough Device Designation from FDA for a prescription digital therapeutic candidate for alcohol use disorder. Banyan is adding an eating disorder program. Verinetics has received a NIDA grant to develop a...
Pear Therapeutics has received Breakthrough Device Designation from FDA for a prescription digital therapeutic candidate for alcohol use disorder. Banyan is adding an eating disorder program. Verinetics has received a NIDA grant to develop a...
Pear Therapeutics has received...
12/03/2021
Behavioral Healthcare Executive
News
Recidivism Rates Drop for Inmates With OUD Treated With Buprenorphine
01/19/2022
In a study of 2 rural Massachusetts jails, risk of recidivism after leaving jail was found to be lower among those with opioid use disorder who were offered buprenorphine during their incarceration vs. those who were not.
In a study of 2 rural Massachusetts jails, risk of recidivism after leaving jail was found to be lower among those with opioid use disorder who were offered buprenorphine during their incarceration vs. those who were not.
In a study of 2 rural...
01/19/2022
Addiction Professional
News
Change Healthcare, ASAM Partner on Utilization Management Software
12/15/2021
Change Healthcare unveiled a software-as-a-service solution (SaaS) developed through a partnership with the American Society of Addiction Medicine designed to streamline operations for addiction treatment providers and payers.
Change Healthcare unveiled a software-as-a-service solution (SaaS) developed through a partnership with the American Society of Addiction Medicine designed to streamline operations for addiction treatment providers and payers.
Change Healthcare unveiled a...
12/15/2021
Behavioral Healthcare Executive
News
Renewed Energy, New Name Highlight Rx Summit's Return to Atlanta
04/18/2022
With a renewed sense of purpose and direction—and a newly christened name—the Rx and Illicit Drug Summit convened in person for the first time since 2019 on Monday in Atlanta.
With a renewed sense of purpose and direction—and a newly christened name—the Rx and Illicit Drug Summit convened in person for the first time since 2019 on Monday in Atlanta.
With a renewed sense of purpose...
04/18/2022
Addiction Professional
News
Business Briefs: RCA, Sheppard Pratt, Howard J. Chudler & Associates, Valiant Recovery
05/27/2022
Recovery Centers of America, Sheppard Pratt, and Valiant Recovery have opened new programs. Chudler & Associates has received a private equity investment.
Recovery Centers of America, Sheppard Pratt, and Valiant Recovery have opened new programs. Chudler & Associates has received a private equity investment.
Recovery Centers of America,...
05/27/2022
Behavioral Healthcare Executive

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use